Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791036504> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2791036504 endingPage "1140" @default.
- W2791036504 startingPage "1132" @default.
- W2791036504 abstract "Background: Ethanolic extract of G. procumbens leaves has been previously shown to possess antihyperlipidemic effects. Objective: This study was designed to prepare caffeoylquinic acids rich and poor fractions of the ethanolic extract using resin column technology and compare their antihyperlipidemic and antioxidant potentials. Results: Among the treatment groups, caffeoylquinic acids rich fraction (F2) and chlorogenic acid (CA, one of the major caffeoylquinic acids) showed potent antihyperlipidemic effects, with significant reductions in total cholesterol (TC), triglycerides (TG), low-density lipoprotein-cholesterol (LDL-C), very low-density lipoprotein-cholesterol (VLDL-C), atherogenic index (AI) and coronary risk index (CRI) (p<0.01 or better) compared to the hyperlipidemic control at the 58 h. The effect was better than that of ethanolic extract. In addition, only F2 significantly increased the high-density lipoproteincholesterol (HDL-C) level (p<0.05). F2 showed better effect than CA alone (60 mg) despite the fact that it only contained 9.81 mg CA/1000 mg dose. The findings suggest that the di-caffeoylquinic acids (86.61 mg/g dose) may also in part be responsible for the potent antihyperlipidemic effect shown by the F2. Likewise, F2 showed the highest antioxidant activity. Thus, simple fractionation of ethanolic extract using the Amberlite XAD-2 resin technique had successfully enriched the caffeoylquinic acids into F2 with improved antihyperlipidemic and antioxidant capacities than that of the ethanolic extract. Conclusion: The resin separation technology may find application in caffeoylquinic acids enrichment of plant extracts for pre-clinical studies. The F2 has potential for development into phytopharmaceuticals as adjunct therapy for management of hyperlipidemia. Keywords: Gynura procumbens, caffeoylquinic acids rich fraction, resin separation, antihyperlipidemic, poloxamer-407, antioxidant." @default.
- W2791036504 created "2018-03-29" @default.
- W2791036504 creator A5023778737 @default.
- W2791036504 creator A5036479695 @default.
- W2791036504 creator A5062673918 @default.
- W2791036504 creator A5079741612 @default.
- W2791036504 creator A5089016927 @default.
- W2791036504 date "2018-04-20" @default.
- W2791036504 modified "2023-09-25" @default.
- W2791036504 title "Caffeoylquinic Acids Rich versus Poor Fractions of Gynura procumbens: Their Comparative Antihyperlipidemic and Antioxidant Potential" @default.
- W2791036504 doi "https://doi.org/10.2174/1389201019666180322111800" @default.
- W2791036504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29564975" @default.
- W2791036504 hasPublicationYear "2018" @default.
- W2791036504 type Work @default.
- W2791036504 sameAs 2791036504 @default.
- W2791036504 citedByCount "5" @default.
- W2791036504 countsByYear W27910365042019 @default.
- W2791036504 countsByYear W27910365042020 @default.
- W2791036504 countsByYear W27910365042021 @default.
- W2791036504 countsByYear W27910365042022 @default.
- W2791036504 countsByYear W27910365042023 @default.
- W2791036504 crossrefType "journal-article" @default.
- W2791036504 hasAuthorship W2791036504A5023778737 @default.
- W2791036504 hasAuthorship W2791036504A5036479695 @default.
- W2791036504 hasAuthorship W2791036504A5062673918 @default.
- W2791036504 hasAuthorship W2791036504A5079741612 @default.
- W2791036504 hasAuthorship W2791036504A5089016927 @default.
- W2791036504 hasConcept C185592680 @default.
- W2791036504 hasConcept C2778004101 @default.
- W2791036504 hasConcept C2778163477 @default.
- W2791036504 hasConcept C2779620165 @default.
- W2791036504 hasConcept C2780072125 @default.
- W2791036504 hasConcept C2780117898 @default.
- W2791036504 hasConcept C2780541478 @default.
- W2791036504 hasConcept C31903555 @default.
- W2791036504 hasConcept C43617362 @default.
- W2791036504 hasConcept C55493867 @default.
- W2791036504 hasConcept C556039675 @default.
- W2791036504 hasConcept C71924100 @default.
- W2791036504 hasConcept C8243546 @default.
- W2791036504 hasConcept C97428945 @default.
- W2791036504 hasConceptScore W2791036504C185592680 @default.
- W2791036504 hasConceptScore W2791036504C2778004101 @default.
- W2791036504 hasConceptScore W2791036504C2778163477 @default.
- W2791036504 hasConceptScore W2791036504C2779620165 @default.
- W2791036504 hasConceptScore W2791036504C2780072125 @default.
- W2791036504 hasConceptScore W2791036504C2780117898 @default.
- W2791036504 hasConceptScore W2791036504C2780541478 @default.
- W2791036504 hasConceptScore W2791036504C31903555 @default.
- W2791036504 hasConceptScore W2791036504C43617362 @default.
- W2791036504 hasConceptScore W2791036504C55493867 @default.
- W2791036504 hasConceptScore W2791036504C556039675 @default.
- W2791036504 hasConceptScore W2791036504C71924100 @default.
- W2791036504 hasConceptScore W2791036504C8243546 @default.
- W2791036504 hasConceptScore W2791036504C97428945 @default.
- W2791036504 hasIssue "14" @default.
- W2791036504 hasLocation W27910365041 @default.
- W2791036504 hasLocation W27910365042 @default.
- W2791036504 hasOpenAccess W2791036504 @default.
- W2791036504 hasPrimaryLocation W27910365041 @default.
- W2791036504 hasRelatedWork W1974789828 @default.
- W2791036504 hasRelatedWork W1984154504 @default.
- W2791036504 hasRelatedWork W1997396883 @default.
- W2791036504 hasRelatedWork W2063467574 @default.
- W2791036504 hasRelatedWork W2102688206 @default.
- W2791036504 hasRelatedWork W2127779084 @default.
- W2791036504 hasRelatedWork W2134715975 @default.
- W2791036504 hasRelatedWork W2284236454 @default.
- W2791036504 hasRelatedWork W3150641388 @default.
- W2791036504 hasRelatedWork W3155576213 @default.
- W2791036504 hasVolume "18" @default.
- W2791036504 isParatext "false" @default.
- W2791036504 isRetracted "false" @default.
- W2791036504 magId "2791036504" @default.
- W2791036504 workType "article" @default.